183 related articles for article (PubMed ID: 18084258)
1. Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
Prasad ML; Barbacioru CC; Rawal YB; Husein O; Wen P
Mod Pathol; 2008 Feb; 21(2):105-14. PubMed ID: 18084258
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers.
Rabban JT; Swain RS; Zaloudek CJ; Chase DR; Chen YY
Mod Pathol; 2006 Oct; 19(10):1351-7. PubMed ID: 16810311
[TBL] [Abstract][Full Text] [Related]
3. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
4. Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma.
Rooper L; Sharma R; Bishop JA
Head Neck Pathol; 2015 Mar; 9(1):79-84. PubMed ID: 24969705
[TBL] [Abstract][Full Text] [Related]
5. The cribriform features of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma: cytokeratin and integrin expression.
Araújo VC; Loducca SV; Sousa SO; Williams DM; Araújo NS
Ann Diagn Pathol; 2001 Dec; 5(6):330-4. PubMed ID: 11745070
[TBL] [Abstract][Full Text] [Related]
6. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
7. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
Schwarz S; Müller M; Ettl T; Stockmann P; Zenk J; Agaimy A
Int J Clin Exp Pathol; 2011 Apr; 4(4):336-48. PubMed ID: 21577319
[TBL] [Abstract][Full Text] [Related]
8. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of vimentin, calponin and HHF-35 in salivary gland tumors.
Cavalcante RB; Lopes FF; Ferreira AS; Freitas Rde A; de Souza LB
Braz Dent J; 2007; 18(3):192-7. PubMed ID: 18176708
[TBL] [Abstract][Full Text] [Related]
10. Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma.
Atiq A; Mushtaq S; Hassan U; Loya A; Hussain M; Akhter N
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2917-2921. PubMed ID: 31653135
[TBL] [Abstract][Full Text] [Related]
11. Polymorphous low-grade adenocarcinoma of minor salivary gland. An immunohistochemical and clinicopathologic study.
Gnepp DR; Chen JC; Warren C
Am J Surg Pathol; 1988 Jun; 12(6):461-8. PubMed ID: 2837102
[TBL] [Abstract][Full Text] [Related]
12. Comparison of p63/p40 Expression With Myoepithelial Markers in Minor Salivary Gland Tumors.
Teixeira LN; Janner ÉC; Teixeira T; Passador-Santos F; Martinez EF; Demasi APD; de Araújo NS; de Araújo VC
Int J Surg Pathol; 2019 Jun; 27(4):360-371. PubMed ID: 30482064
[TBL] [Abstract][Full Text] [Related]
13. [Myoepithelial differentiation markers in salivary gland neoplasia].
Scarpellini F; Marucci G; Foschini MP
Pathologica; 2001 Dec; 93(6):662-7. PubMed ID: 11785118
[TBL] [Abstract][Full Text] [Related]
14. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
[TBL] [Abstract][Full Text] [Related]
15. Maspin and MCM2 immunoprofiling in salivary gland carcinomas.
Ghazy SE; Helmy IM; Baghdadi HM
Diagn Pathol; 2011 Sep; 6():89. PubMed ID: 21943228
[TBL] [Abstract][Full Text] [Related]
16. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma.
Beltran D; Faquin WC; Gallagher G; August M
J Oral Maxillofac Surg; 2006 Mar; 64(3):415-23. PubMed ID: 16487803
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Expression of CD-117 (c-KIT), P-53 and Ki-67 in Adenoid Cystic Carcinoma of Palate.
Bajpai M; Pardhe N
J Coll Physicians Surg Pak; 2018 Jun; 28(6):S130-S132. PubMed ID: 29866247
[TBL] [Abstract][Full Text] [Related]
18. Melanin bearing myoepithelial cells in a pigmented salivary gland carcinoma: a new avatar of myoepithelial cell? A case report.
Desai SS; Borges AM
Virchows Arch; 2006 Apr; 448(4):521-3. PubMed ID: 16429306
[TBL] [Abstract][Full Text] [Related]
19. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.
Reyes C; Jorda M; Gomez-Fernández C
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):283-6. PubMed ID: 22935826
[TBL] [Abstract][Full Text] [Related]
20. Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma.
Baba S; Akashi T; Kayamori K; Ohuchi T; Ogawa I; Kubota N; Nakano K; Nagatsuka H; Hasegawa H; Matsuzaka K; Tomii S; Uchida K; Katsuta N; Sekiya T; Ando N; Miura K; Ishibashi H; Ariizumi Y; Asakage T; Michi Y; Harada H; Sakamoto K; Eishi Y; Okubo K; Ikeda T
Pathol Int; 2021 Feb; 71(2):113-123. PubMed ID: 33333616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
